Cargando…

Outcome of patients on second line antiretroviral therapy under programmatic condition in India

BACKGROUND: The National AIDS Control Organization of India has been providing free second line antiretroviral therapy (ART) since 2008. This observational study reports the survival and virologic suppression of patients on second-line ART under programmatic condition and type of mutations acquired...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakravarty, Jaya, Sundar, Shyam, Chourasia, Ankita, Singh, Pallav Narayan, Kurle, Swarali, Tripathy, Srikanth P., Chaturbhuj, Devidas N, Rai, Madhukar, Agarwal, Amit Kumar, Mishra, Rabindra Nath, Paranjape, Ramesh S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647630/ https://www.ncbi.nlm.nih.gov/pubmed/26572102 http://dx.doi.org/10.1186/s12879-015-1270-8

Ejemplares similares

Evaluation of a Cost Effective In-House Method for HIV-1 Drug Resistance Genotyping Using Plasma Samples
por: Chaturbhuj, Devidas N., et al.
Publicado: (2014)

Response to second line antiretroviral therapy in India
por: Singh, Anup, et al.
Publicado: (2012)

Emergence of Drug Resistance in Human Immunodeficiency Virus Type 1 Infected Patients from Pune, India, at the End of 12 Months of First Line Antiretroviral Therapy Initiation
por: Patil, Rajesh T., et al.
Publicado: (2014)

Optimal timing for initiation of antiretroviral therapy: a prospective study on treatment naive HIV patients
por: Chakravarty, Jaya, et al.
Publicado: (2012)

Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India
por: Karade, Santosh K., et al.
Publicado: (2016)

Determinants of survival in adult HIV patients on antiretroviral therapy in Eastern Uttar Pradesh: A prospective study
por: Chakravarty, Jaya, et al.
Publicado: (2014)

Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2015)

Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India
por: Chakravarty, Jaya, et al.
Publicado: (2016)

Factors affecting default among pre-ART patients in Eastern Uttar Pradesh
por: Kansal, Sangeeta, et al.
Publicado: (2012)

Cloning, Expression and Purification of L. Donovani Specific Antigen for Serodiagnosis of Visceral Leishmaniasis
por: Kumar, Dinesh, et al.
Publicado: (2013)

Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2014)

HIV-1 pol gene diversity and molecular dating of subtype C from Sri Lanka
por: Patil, Ajit, et al.
Publicado: (2020)

Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
por: Sudarshan, Medhavi, et al.
Publicado: (2014)

Study the drug adherence and possible factor influencing drug adherence in HIV/AIDS patients in north eastern part of India
por: Meena, Lalit Prashant, et al.
Publicado: (2014)

Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat Protein
por: Kulkarni, Archana, et al.
Publicado: (2017)

Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India
por: Gautam, Abhilasha, et al.
Publicado: (2018)

Antimony Toxicity
por: Sundar, Shyam, et al.
Publicado: (2010)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Drug Resistance in Leishmaniasis
por: Chakravarty, Jaya, et al.
Publicado: (2010)

A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections
por: Sawant, Jyoti, et al.
Publicado: (2023)

Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies
por: Mudavath, Shyam Lal, et al.
Publicado: (2014)

Development of subtype specific RealTime PCR based growth competition assay for assessing the replication fitness of drug resistant viruses of Indian HIV-1 clade C
por: Hingankar, Nitin K, et al.
Publicado: (2014)

Association of Interleukin-18 Gene Polymorphism with Susceptibility to Visceral Leishmaniasis in Endemic Area of Bihar, an Indian Population
por: Kumar, Dinesh, et al.
Publicado: (2014)

Why do Patients in Pre-Anti Retroviral Therapy (ART) Care Default: A Cross-Sectional Study
por: Chakravarty, Jaya, et al.
Publicado: (2016)

Use of first line antiretroviral therapy from a free ART programme clinic in Pune, India - A preliminary report
por: Ghate, Manisha, et al.
Publicado: (2013)

PYRE insertion within HIV-1 subtype C p6-Gag functions as an ALIX-dependent late domain
por: Chaturbhuj, Devidas, et al.
Publicado: (2018)

Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
por: Singh, Om Prakash, et al.
Publicado: (2016)

Exploring the Evolutionary History and Phylodynamics of Human Immunodeficiency Virus Type 1 Outbreak From Unnao, India Using Phylogenetic Approach
por: Patil, Ajit, et al.
Publicado: (2022)

Diagnosis of Indian Visceral Leishmaniasis by Nucleic Acid Detection Using PCR
por: Srivastava, Pankaj, et al.
Publicado: (2011)

Metabolic changes in the patients on second-line highly active antiretroviral therapy (HAART): A prospective cohort study from north India
por: Meena, Durga S., et al.
Publicado: (2020)

Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India
por: Singh, Abhishek Kumar, et al.
Publicado: (2023)

Deconstructing programmatic assessment
por: Wilkinson, Tim J, et al.
Publicado: (2018)

Evidence of improving antiretroviral therapy treatment delays: an analysis of eight years of programmatic outcomes in Blantyre, Malawi
por: Sloan, Derek J, et al.
Publicado: (2013)

Diagnostic performance of patient self‐collected oral swab (tongue and cheek) in comparison with healthcare worker‐collected nasopharyngeal swab for severe acute respiratory syndrome coronavirus‐2 detection
por: Mane, Arati, et al.
Publicado: (2022)

Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat All
por: Ford, Nathan, et al.
Publicado: (2018)

Addressing antiretroviral therapy-related diagnostic coverage gaps across South Africa using a programmatic approach
por: Cassim, Naseem, et al.
Publicado: (2018)

Assessing the capacity and findings of routine programmatic data in Kenya to guide decision-making around contraceptives and antiretroviral therapy
por: Tippett Barr, Beth A.
Publicado: (2021)

T-cell Epitopes Identified by BALB/c Mice Immunized with Vaccinia Expressing HIV-1 Gag lie within immunodominant Regions Recognized by HIV-infected Indian Patients
por: Shete, Ashwini V, et al.
Publicado: (2011)

On the issue of costs in programmatic assessment
por: van der Vleuten, Cees P. M., et al.
Publicado: (2016)

COVID‐19 and programmatic assessment
por: Bala, Laksha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_np2mqu51lmci7kgeuqf7la1vam